ScholarLens Back to search
2010•Biaoji mianyi fenxi yu linchuangRequires access

Clinical Value of CA125,CA72-4 and CEA Detection in Early Diagnosis of Ovarian Cancer

Hui Jing

Open publisher page 0 citations

Abstract

To explore the clinical values of combined detection of serum CA125,CA72-4 and CEA levels in the early diagnosis of ovarian cancer,the serum CA125,CA72-4 and CEA levels in 112 patients with ovarian cancer,185 patients with benign ovarian tumor and 100 healthy women controls were measured by electrochemical luminescence immunoassay(ECLIA).The results showed that serum CA125,CA72-4 and CEA levels and positive rate in patients with ovarian cancer were significantly higher that of in patients with benign ovarian tumor and healthy controls(P0.01).The positive rates of CA125,CA72-4 and CEA in patients with ovarian cancer were 86.61%,67.86% and 49.11%,respectively.The positive rate of three markers combined detection was 91.96%.The combined detection of the three markers may increase the positive rate in the early diagnosis of ovarian cancer,and help to differentiate the benign and malignant ovarian tumor.

About this research paper

What this paper is about

To explore the clinical values of combined detection of serum CA125,CA72-4 and CEA levels in the early diagnosis of ovarian cancer,the serum CA125,CA72-4 and CEA levels in 112 patients with ovarian cancer,185 patients with benign ovarian tumor and 100 healthy women controls were measured by electrochemical luminescence immunoassay(ECLIA).The results showed that serum CA125,CA72-4 and CEA levels and positive rate in patients with ovarian cancer were significantly higher that of in patients with benign ovarian tumor and healthy controls(P0.01).The positive rates of CA125,CA72-4 and CEA in patients with ovarian cancer were 86.61%,67.86% and 49.11%,respectively.The positive rate of three markers combined detection was 91.96%.The combined detection of the three markers may increase the positive rate in the early diagnosis of ovarian cancer,and help to differentiate the benign and malignant ovarian tumor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To explore the clinical values of combined detection of serum CA125,CA72-4 and CEA levels in the early diagnosis of ovarian cancer,the serum CA125,CA72-4 and CEA levels in 112 patients with ovarian cancer,185 patients with benign ovarian tumor and 100 healthy women controls were measured by electrochemical luminescence immunoassay(ECLIA).The results showed that serum CA125,CA72-4 and CEA levels and positive rate in patients with ovarian cancer were significantly higher that of in patients with benign ovarian tumor and healthy controls(P0.01).The positive rates of CA125,CA72-4 and CEA in patients with ovarian cancer were 86.61%,67.86% and 49.11%,respectively.The positive rate of three markers combined detection was 91.96%.The combined detection of the three markers may increase the positive rate in the early diagnosis of ovarian cancer,and help to differentiate the benign and malignant ovarian tumor.

Key concepts: Medicine, Ovarian cancer, Internal medicine, Ovarian tumor, Oncology, Cancer, Tumor marker, Clinical diagnosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Value of CA125,CA72-4 and CEA Detection in Early Diagnosis of Ovarian Cancer — Research Paper | ScholarLens